![](/img/cover-not-exists.png)
PDB26 ESTIMATED RENAL AND CARDIOVASCULAR OUTCOMES AND COST OFFSETS IN PATIENTS WITH TYPE 2 DIABETES (T2D) AND DIABETIC NEPHROPATHY (DKD) TREATED WITH CANAGLIFLOZIN
Willis, M., Durkin, M., Neslusan, C., Traina, S., Nilsson, A.Volume:
23
Journal:
Value in Health
DOI:
10.1016/j.jval.2020.04.214
Date:
May, 2020
File:
PDF, 384 KB
2020